Carregant...
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
BACKGROUND: The triple negative breast cancer (TNBC) paradox marks a major challenge in the treatment-decision making process. TNBC patients generally respond better to neoadjuvant chemotherapy compared to other breast cancer patients; however, they have a substantial higher risk of disease recurren...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6317205/ https://ncbi.nlm.nih.gov/pubmed/30602372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1757-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|